Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.1B
Enterprise Value5.81B
P/E Ratio-18.8
PEG Ratio-0.16
Price/Sales Ratio2.09
Price/Book Ratio4.35
Enterprise/Revenue2.39
Enterprise/EBITDA-53.33

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.09
AD

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.21

Income Statement

Revenue2.27B
Revenue/Share2.15
Gross Profit1.13B
EBITDA-29.17M
Net Income-288.58M
Diluted EPS-0.27

Balance Sheet

Total Cash983.06M
Total Cash/Share0.9
Total Debt1.68B
Total Debt/Equity1.49
Current Ratio0.79
Book Value Per Share1.11

Price History

52-Week Change-18.18
52-Week High5.84
52-Week Low3.7
Moving Average 50 Days4.88
Moving Average 200 Days4.84

Statistics

Average Volume43.23M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.13
Last Split Factor17:10
Last Split DateSeptember 23, 2019
AD